NCT04834232 is a clinical trial of compression therapy in Venous Ulcer Recurrent, sponsored by Assiut University.

Who is sponsoring NCT04834232?

NCT04834232 is sponsored by Assiut University.

What drugs are being tested in NCT04834232?

Interventions in NCT04834232: compression therapy, iliac vein stenting.

What condition does NCT04834232 study?

NCT04834232 studies Venous Ulcer Recurrent.

Is NCT04834232 still recruiting?

NCT04834232 is currently status unknown. Last updated 8 April 2021.

Last reviewed 2021-04-08 · How we verify

NCT04834232

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Iliac Vein Stenting and Compression Therapy in Recurrent Venous Ulceration

Status unknown Last updated 8 April 2021

What this trial tests

trial testing compression therapy in Venous Ulcer Recurrent in 100 participants. Status unknown.

Timeline

1 May 2021

Primary endpoint
1 December 2021

1 December 2021

Quick facts

Lead sponsor	Assiut University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	100
Start date	1 May 2021
Primary completion	1 December 2021
Estimated completion	1 December 2021
Sites	1 location across Egypt

Drugs / interventions tested

compression therapy
iliac vein stenting

Conditions studied

Venous Ulcer Recurrent — all drugs for Venous Ulcer Recurrent →

Sponsor

Assiut University

Who can join

Adults 12 to 75, any sex, with Venous Ulcer Recurrent. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Comparing the result of of iliac vein stenting and compression therapy in management of recurrent venous ulceration.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04834232 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 8 April 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04834232.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing